Research details developments in the flu vaccine market forecast 2017-2024

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States.

United States flu vaccine market is expected to reach nearly US 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Market key players are: Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and others.

Ask for Report: www.ingeniousreports.com/Flu-Vac…-2017-2024

Major Flu Vaccines covered under this report are:

• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• Fluvax

Key Topics Covered in the Report:

• Market Overview: United States Flu Vaccine Market (2010 - 2024)
• United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024)
• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
• Reimbursement & Regulatory System in the US Flu Vaccine Market
• Mergers, Acquisitions, Key Agreements & Collaborations
• Promising Flu Vaccine in Clinical Development
• Flu Vaccine Clinical Trial Insights by Phase, Company & Country
• Key Drivers and Inhibitors of the US Flu Vaccine Market
• Key Companies Analysis

Table of Content:

1. Executive Summary
2. Market Overview: United States Flu Vaccine Market (2010 - 2024)
3. United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024)
4. Key Drivers and Inhibitors of the United States Flu Vaccine Market
5. United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
6. United States Flu Vaccine Market – Reimbursement & Regulatory System
7. Market Dynamics – Mergers, Acquisitions, Key Agreements & Collaborations
8. Flu Vaccine – Promising Vaccine in Clinical Development
9. Flu Vaccine – Clinical Trial Insights by Phase, Company & Country
10. Key Companies Analysis

List of Table:

United States – Pediatric Flu Vaccine Price, 2017 – 2018

United States – Flu Vaccine Production, Supply, and Allocation

Total Percentage of Flu Vaccines Released by Week, 2016 – 2017

Adjusted Vaccine Effectiveness Estimates for Flu Seasons, 2005 – 2016

United States – Simplified Regulatory Pathway from Preclinical to the Marketing Authorization

List of Figure:

United States – Forecast for Flu Vaccine Market (Million US),2017 – 2024

United States – Number of Adults Vaccinated (Thousand),2010 – 2016

Sanofi Pasteur – Flu Vaccine Net Sales (Million US),2011 – 2016

GSK – Forecast for Flu Vaccine Net Sales (Million US),2017 – 2024

View Full Report: www.ingeniousreports.com/Flu-Vac…-2017-2024

News From

IngeniousReports.com
Category: Industry Reports & Market Analysis Profile: IngeniousReports provides one-stop solution platform for all technology, business, and market research dilemmas. We, at IngeniousReports, collaborate with leading global publishers of technology, business and market intelligence reports to industries, individuals and organizations with the endeavor of supporting them in making strategic and cost-effective business decisions.